• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Low rates of liver injury in edoxaban users: Evidence from a territory-wide observational cohort study.

作者信息

Zhou Jiandong, Leung Keith Sai Kit, Kong Dicken, Lee Sharen, Liu Tong, Wai Abraham Ka Chung, Chang Carlin, Zhang Qingpeng, Tse Gary

机构信息

School of Data Science, City University of Hong Kong, Hong Kong, China.

Aston Medical School, Aston University, Birmingham, UK.

出版信息

Clin Cardiol. 2021 Jul;44(7):886-889. doi: 10.1002/clc.23570. Epub 2021 Feb 16.

DOI:10.1002/clc.23570
PMID:33590891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8259145/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff1f/8259145/4a4beaf3a4ef/CLC-44-886-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff1f/8259145/145bd12bfe31/CLC-44-886-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff1f/8259145/4a4beaf3a4ef/CLC-44-886-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff1f/8259145/145bd12bfe31/CLC-44-886-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff1f/8259145/4a4beaf3a4ef/CLC-44-886-g001.jpg

相似文献

1
Low rates of liver injury in edoxaban users: Evidence from a territory-wide observational cohort study.依度沙班使用者肝损伤发生率低：一项全地区观察性队列研究的证据。
Clin Cardiol. 2021 Jul;44(7):886-889. doi: 10.1002/clc.23570. Epub 2021 Feb 16.
2
Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study.依度沙班上市后第一年直接口服抗凝剂的使用：一项丹麦全国性药物利用研究。
Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):174-181. doi: 10.1002/pds.4350. Epub 2017 Nov 15.
3
Real-life Performance of Edoxaban in Elderly Patients With Atrial Fibrillation: a Multicenter Propensity Score-Matched Cohort Study.依度沙班在老年房颤患者中的真实世界疗效：一项多中心倾向性评分匹配队列研究。
Clin Ther. 2019 Aug;41(8):1598-1604. doi: 10.1016/j.clinthera.2019.04.041. Epub 2019 May 28.
4
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease.依度沙班与华法林用于伴有肝脏疾病病史的心房颤动患者
J Am Coll Cardiol. 2019 Jul 16;74(2):179-189. doi: 10.1016/j.jacc.2019.04.061.
5
A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.直接口服因子 Xa 抑制剂依度沙班可改善载脂蛋白 E 缺陷小鼠血管损伤和血栓形成后的新生内膜增生。
J Thromb Thrombolysis. 2018 Jul;46(1):95-101. doi: 10.1007/s11239-018-1673-7.
6
The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitor.抗血小板药物阿司匹林和萘普生对直接 Xa 因子抑制剂抗凝药依度沙班的药代动力学和药效学的影响。
J Cardiovasc Pharmacol. 2013 Aug;62(2):212-21. doi: 10.1097/FJC.0b013e3182970991.
7
Treatment of acute exacerbation of liver-cirrhosis-associated portal vein thrombosis with direct-acting oral anticoagulant, edoxaban, used as an initial treatment in the early postoperative period after abdominal surgery: a case report.腹部手术后早期术后阶段使用直接口服抗凝剂依度沙班治疗肝硬化相关门静脉血栓形成急性加重：一例报告
J Med Case Rep. 2021 Feb 10;15(1):52. doi: 10.1186/s13256-020-02651-y.
8
The impact of a three-factor prothrombin complex concentrate on the anticoagulatory effects of the factor Xa inhibitor edoxaban.三因子凝血酶原复合物浓缩物对因子 Xa 抑制剂依度沙班抗凝作用的影响。
Thromb Res. 2015 Oct;136(4):825-31. doi: 10.1016/j.thromres.2015.07.012. Epub 2015 Jul 16.
9
Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation.依度沙班对凝血酶依赖性血小板聚集的影响。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620948585. doi: 10.1177/1076029620948585.
10
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study.依度沙班用于欧洲房颤患者常规临床实践治疗的设计和原理研究（ETNA-AF-Europe）
J Cardiovasc Med (Hagerstown). 2019 Feb;20(2):97-104. doi: 10.2459/JCM.0000000000000737.

本文引用的文献

1
Acute ischemic stroke management: concepts and controversies.A narrative review.急性缺血性卒中的管理：概念与争议。一篇叙述性综述。
Expert Rev Neurother. 2021 Jan;21(1):65-79. doi: 10.1080/14737175.2021.1836963. Epub 2020 Nov 2.
2
Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation: a propensity-weighted nationwide cohort study.口服抗凝剂与非瓣膜性心房颤动患者急性肝损伤的风险：一项倾向评分加权的全国性队列研究。
Sci Rep. 2020 Jul 15;10(1):11624. doi: 10.1038/s41598-020-68304-8.
3
Real-world use of nonvitamin K antagonist oral anticoagulant in atrial fibrillation patients with liver disease: A meta-analysis.
非维生素 K 拮抗剂口服抗凝剂在伴有肝脏疾病的心房颤动患者中的真实世界应用：一项荟萃分析。
Clin Cardiol. 2020 Jul;43(7):676-683. doi: 10.1002/clc.23408. Epub 2020 Jun 17.
4
Liver injury caused by oral anticoagulants: A population-based retrospective cohort study.口服抗凝剂所致肝损伤：一项基于人群的回顾性队列研究。
Liver Int. 2020 Aug;40(8):1895-1900. doi: 10.1111/liv.14559. Epub 2020 Jun 25.
5
Association Between Nonvitamin K Antagonist Oral Anticoagulants or Warfarin and Liver Injury: A Cohort Study.非维生素 K 拮抗剂口服抗凝剂或华法林与肝损伤的关联：一项队列研究。
Am J Gastroenterol. 2020 Sep;115(9):1513-1524. doi: 10.14309/ajg.0000000000000678.
6
Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study.口服抗凝剂降低房颤患者痴呆风险：一项基于人群的队列研究。
Heart Rhythm. 2020 May;17(5 Pt A):706-713. doi: 10.1016/j.hrthm.2020.01.007. Epub 2020 Jan 10.
7
Superior safety of direct oral anticoagulants compared to Warfarin in patients with atrial fibrillation and underlying cancer: a national veterans affairs database study.直接口服抗凝剂与华法林相比，在患有心房颤动和潜在癌症患者中的安全性更高：一项国家退伍军人事务数据库研究。
J Geriatr Cardiol. 2019 Sep;16(9):706-709. doi: 10.11909/j.issn.1671-5411.2019.09.006.
8
Efficacy and Safety of Direct Oral Anticoagulants for Secondary Prevention of Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies.直接口服抗凝剂用于癌症相关血栓形成二级预防的疗效和安全性：随机对照试验和前瞻性队列研究的系统评价与荟萃分析
Front Pharmacol. 2019 Jul 10;10:773. doi: 10.3389/fphar.2019.00773. eCollection 2019.
9
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease.依度沙班与华法林用于伴有肝脏疾病病史的心房颤动患者
J Am Coll Cardiol. 2019 Jul 16;74(2):179-189. doi: 10.1016/j.jacc.2019.04.061.
10
Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.非维生素 K 拮抗剂口服抗凝剂与严重肝损伤风险。
J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009.